Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.
Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I.
Ravina B, et al. Among authors: ascherio a.
Mov Disord. 2012 Sep 15;27(11):1392-7. doi: 10.1002/mds.25157. Epub 2012 Sep 13.
Mov Disord. 2012.
PMID: 22976926
Free PMC article.